FERRING RES LTD has a total of 14 patent applications. Its first patent ever was published in 1985. It filed its patents most often in United Kingdom, Norway and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are AbbVie Deutschland GmbH and Co KG, CAMBRIDGE BIOCLINICAL LTD and CELLTECH THERAPEUTICS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 7 | |
#2 | Norway | 2 | |
#3 | Canada | 1 | |
#4 | Czechia | 1 | |
#5 | Finland | 1 | |
#6 | Hungary | 1 | |
#7 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Peptides | |
#5 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Szelke Michael | 8 |
#2 | Semple Graeme | 8 |
#3 | Ryder Hamish | 7 |
#4 | Ohta Mitsuaki | 7 |
#5 | Nishida Akito | 7 |
#6 | Miyata Keiji | 7 |
#7 | Satoh Masato | 7 |
#8 | Ishii Masato | 5 |
#9 | Baker Graham | 1 |
#10 | Kendrick David Alan | 1 |
Publication | Filing date | Title |
---|---|---|
GB9520368D0 | Ice inhibitor | |
GB9510203D0 | Novel endothelin receptor antagonists | |
GB9503788D0 | Ice inhibitor | |
GB9416078D0 | Peptide inhibitors of pro-interleukin-1beta converting enzyme | |
GB9318637D0 | Enzyme inhibitors | |
GB8515750D0 | Enzyme inhibitors |